Percutaneous Hepatic Perfusion to Treat Metastatic Malignant Melanoma
In this two-minute video, Dr. H. Richard Alexander, professor of surgery at the University of Maryland School of Medicine and surgical oncologist at the University of Maryland Greenebaum Cancer Center, explains a new method that his team helped to develop for treating patients with metastatic melanoma that has spread to the liver. A recent nationwide clinical trial that tested the procedure, known as percutaneous hepatic perfusion, showed that it was very effective in improving longevity and quality of life for patients with this condition. Dr. Alexander talks about the results of this clinical trial and the implications these results may have on the future treatment of melanoma and possibly other types of cancer that spread to the liver.
This page was last updated: August 7, 2013